Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | CHEK2 |
| Variant | Y220C |
| Impact List | missense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | CHEK2 Y220C lies within the protein kinase domain of the Chek2 protein (UniProt.org). Y220C results in intermediate Chek2 autophosphorylation and decreased Kap1 phosphorylation in CHEK2-null cells in culture (PMID: 37449874), and therefore, is predicted to lead to a loss of Chek2 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
CHEK2 mutant CHEK2 inact mut CHEK2 Y220C |
| Transcript | NM_007194.4 |
| gDNA | chr22:g.28719419T>C |
| cDNA | c.659A>G |
| Protein | p.Y220C |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_007194.4 | chr22:g.28719419T>C | c.659A>G | p.Y220C | RefSeq | GRCh38/hg38 |
| NM_145862.2 | chr22:g.28719419T>C | c.659A>G | p.Y220C | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|